Clinical Trial

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects

Name: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects — clinical trial record (NCT07057726)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated July 10, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the safety, tolerability, and pharmacokinetics of SSS39 injection in healthy Chinese subjects

Trial Details

NCT Number	NCT07057726
Lead Sponsor	Shenyang Sunshine Pharmaceutical Co., LTD.
Conditions	Safety and Tolerability in Healthy Volunteers
Enrollment	48 participants
Start Date	2024-10-09
Primary Completion	2025-10 (estimated)
Study Completion	2025-10 (estimated)
Updated on ClinicalTrials.gov	2025-07-10